CALCULATE YOUR SIP RETURNS

Top 5 Losers of Nifty Pharma Index on April 7, 2025: Biocon Tanks Nearly 6%

Written by: Akshay ShivalkarUpdated on: Apr 9, 2025, 9:24 PM IST
Top 5 Pharma losers: Biocon tanks 6%, Ipca, Ajanta, Granules, Glenmark drop over 3% amid profit booking on April 7.
Top 5 Losers of Nifty Pharma Index on April 7, 2025: Biocon Tanks Nearly 6%
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

The Nifty Pharma index ended lower on April 7, 2025, following broad-based selling across key constituents. Several pharmaceutical stocks saw notable intraday declines, pulling the index down by nearly 2.75%. The trading session was marked by strong volumes and intraday volatility in major pharma counters.

Nifty Pharma Index Movement on April 7

The Nifty Pharma index closed at 19,995.50, down 2.75% for the day, after opening lower at 19,122.70 and fluctuating between 19,121.10 and 20,150.00. This decline follows a previous close of 20,560.00 on April 3, 2025.

Over the past 30 days, the index has gained 0.89%, showing a slight monthly improvement. While it remains above its 52-week low of 17,904.75, the index is still well below its 52-week high of 23,907.90.

Top 5 Nifty Pharma Losers

SYMBOL OPEN CLOSE %CHNG VOLUME

(shares)

VALUE

(₹ Crores)

BIOCON 299.1 308.15 -5.99 26,47,332 81.11
IPCALAB 1,168.20 1,316.00 -5.95 2,58,829 34.05
AJANTPHARM 2,349.10 2,380.00 -4.23 64,202 15.34
GRANULES 440.9 439.5 -3.78 7,64,571 33.29
GLENMARK 1,360.00 1,443.50 -3.76 5,51,499 79.55

1. Biocon

Biocon closed at ₹308.15, down ₹19.65 or 5.99% from its previous close of ₹327.80. The stock opened at ₹299.10, reached a high of ₹311.75, and touched a low of ₹299.00. A total of 26,47,332 shares were traded, amounting to a turnover of ₹81.11 crore. Over the last 30 days, the stock has declined 1.77% but gained 20.98% over the year.

2. IPCA Laboratories

IPCA Laboratories closed at ₹1,316.00, registering a drop of ₹83.25 or 5.95% from its previous close of ₹1,399.25. It opened at ₹1,168.20 and traded between ₹1,168.20 and ₹1,350.70 during the day. The volume stood at 2,58,829 shares with a total turnover of ₹34.05 crore. The stock has risen 4.96% over the last month and 6.44% over the past year.

3. Ajanta Pharma

Ajanta Pharma ended the session at ₹2,380.00, falling ₹105.25 or 4.23% from the previous close of ₹2,485.25. It opened at ₹2,349.10, hit a high of ₹2,433.50, and a low of ₹2,327.30. A total of 64,202 shares were traded, generating a turnover of ₹15.34 crore. Over the past 30 days, the stock has fallen 3.03% but is up 13.92% year-on-year.

4. Granules India

Granules India closed at ₹439.50, down ₹17.25 or 3.78% compared to its previous close of ₹456.75. The stock opened at ₹440.90, touched a high of ₹443.15, and slipped to a low of ₹426.90. Trading volume stood at 7,64,571 shares, with a turnover of ₹33.29 crore. The stock is down 7.38% in the last 30 days but has risen 0.94% over the past year.

5. Glenmark Pharmaceuticals

Glenmark ended the day at ₹1,443.50, a decline of ₹56.35 or 3.76% from its previous close of ₹1,499.85. It opened at ₹1,360.00 and moved between ₹1,360.00 and ₹1,471.20 during the session. The stock recorded a volume of 5,51,499 shares, translating to a turnover of ₹79.55 crore. Glenmark has risen 6.8% over the last 30 days and delivered a 47.42% gain over the past year.

Index Contribution by Top 5 Losers

The fall in the index was primarily driven by Biocon, which reported a trading volume of 26.47 lakh shares and a turnover of ₹81.11 crore. IPCA Laboratories and Glenmark Pharmaceuticals followed with high turnover and intraday declines.

Ajanta Pharma and Granules India, while having relatively lower volumes, also contributed to the downward movement of the index. Collectively, these five stocks exerted significant pressure on the Nifty Pharma index during the trading session.

Conclusion

The Nifty Pharma index registered a 2.75% decline on April 7, 2025, led by losses in Biocon, Ipca Laboratories, Ajanta Pharma, Granules India, and Glenmark Pharmaceuticals. These counters accounted for the majority of the day’s losses, contributing to the fall in the overall index.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Apr 7, 2025, 9:18 PM IST

Akshay Shivalkar

Akshay Shivalkar is a financial content specialist who strategises and creates SEO-optimised content on the stock market, mutual funds, and other investment products. With experience in fintech and asset management, he simplifies complex financial concepts to help investors make informed decisions through his writing.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3 Cr+ happy customers